Sort by
Items per page

Send to

Choose Destination

Best matches for Bénard J[au]:

Fertility preservation in Turner syndrome. Grynberg M et al. Fertil Steril. (2016)

Shedding light on the fertility preservation debate in women with endometriosis: a swot analysis. Streuli I et al. Eur J Obstet Gynecol Reprod Biol. (2018)

Fertility Preservation in Endocrine Disorders during Transition for Girls. Bénard J et al. Endocr Dev. (2018)

Search results

Items: 1 to 50 of 213


The effect of mind-body interventions on psychological and pregnancy outcomes in infertile women: a systematic review.

Gaitzsch H, Benard J, Hugon-Rodin J, Benzakour L, Streuli I.

Arch Womens Ment Health. 2020 Jan 2. doi: 10.1007/s00737-019-01009-8. [Epub ahead of print] Review.


Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients.

Sonigo C, Sermondade N, Calvo J, Benard J, Sifer C, Grynberg M.

Eur J Obstet Gynecol Reprod Biol X. 2019 May 11;4:100049. doi: 10.1016/j.eurox.2019.100049. eCollection 2019 Oct.


[Preimplantation genetic testing].

Benard J, Targa C, Murisier F, Paoloni-Giacobino A, Streuli I.

Rev Med Suisse. 2019 Jan 9;15(N° 632-633):53-56. French.


Comparison of GnRH agonist and hCG for priming in vitro maturation cycles in cancer patients undergoing urgent fertility preservation.

El Hachem H, Sonigo C, Benard J, Presse M, Sifer C, Sermondade N, Grynberg M.

PLoS One. 2018 Dec 6;13(12):e0208576. doi: 10.1371/journal.pone.0208576. eCollection 2018.


Shedding light on the fertility preservation debate in women with endometriosis: a swot analysis.

Streuli I, Benard J, Hugon-Rodin J, Chapron C, Santulli P, Pluchino N.

Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:172-178. doi: 10.1016/j.ejogrb.2018.08.577. Epub 2018 Aug 22. Review.


Fertility Preservation in Endocrine Disorders during Transition for Girls.

Bénard J, Sermondade N, Grynberg M.

Endocr Dev. 2018;33:128-148. doi: 10.1159/000487530. Epub 2018 Jun 8.


[Fertility and cancer in young adults : cured, but what about having children ?]

Gaignard ME, Bénard J, Lang N.

Rev Med Suisse. 2018 Mar 14;14(598):558-562. French.


[Hormonal treatments and venous thrombosis in women].

Hugon-Rodin J, Blondon M, Bénard J, Plu-Bureau G, Streuli I.

Rev Med Suisse. 2017 Oct 25;13(580):1821-1825. French.


Colon inflammatory fibroid polyp in a patient with von Recklinghausen's disease: endoscopic aspect with narrow-band imaging and magnification.

Benard J, Rivory J, Rostain F, Montuclard C, Hervieu V, Ponchon T, Pioche M.

Endoscopy. 2018 Jan;50(1):E5-E7. doi: 10.1055/s-0043-119983. Epub 2017 Oct 17. No abstract available.


Revisiting the human polypeptide GalNAc-T1 and T13 paralogs.

Festari MF, Trajtenberg F, Berois N, Pantano S, Revoredo L, Kong Y, Solari-Saquieres P, Narimatsu Y, Freire T, Bay S, Robello C, Bénard J, Gerken TA, Clausen H, Osinaga E.

Glycobiology. 2017 Jan;27(2):140-153. doi: 10.1093/glycob/cww111. Epub 2016 Nov 22.


Freezing oocytes or embryos after controlled ovarian hyperstimulation in cancer patients: the state of the art.

Bénard J, Duros S, El Hachem H, Sonigo C, Sifer C, Grynberg M.

Future Oncol. 2016 Jul;12(14):1731-41. doi: 10.2217/fon-2016-0095. Epub 2016 May 17. Review.


[Fertility preservation in women of the childbearing age: Indications and strategies].

Bénard J, Calvo J, Comtet M, Benoit A, Sifer C, Grynberg M.

J Gynecol Obstet Biol Reprod (Paris). 2016 May;45(5):424-44. doi: 10.1016/j.jgyn.2016.02.005. Epub 2016 Mar 22. Review. French.


[A prospective study to compare the efficiency of oocyte vitrification using closed or open devices].

Sarandi S, Herbemont C, Sermondade N, Benoit A, Sonigo C, Poncelet C, Benard J, Gronier H, Boujenah J, Grynberg M, Sifer C.

Gynecol Obstet Fertil. 2016 May;44(5):280-4. doi: 10.1016/j.gyobfe.2016.02.003. Epub 2016 Mar 8. French.


[Embryo development in two single-step media: Analysis of 2059 sibling oocytes].

Durand M, Sermondade N, Herbemont C, Benard J, Gronier H, Boujenah J, Cédrin-Durnerin I, Poncelet C, Grynberg M, Sifer C.

Gynecol Obstet Fertil. 2016 Mar;44(3):163-7. doi: 10.1016/j.gyobfe.2016.01.005. Epub 2016 Feb 18. French.


Fertility preservation in Turner syndrome.

Grynberg M, Bidet M, Benard J, Poulain M, Sonigo C, Cédrin-Durnerin I, Polak M.

Fertil Steril. 2016 Jan;105(1):13-9. doi: 10.1016/j.fertnstert.2015.11.042. Epub 2015 Dec 8. Review.


WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.

Masserot C, Liu Q, Nguyen E, Gattolliat CH, Valteau-Couanet D, Bénard J, Huber C, Ségal-Bendirdjian E.

Mol Oncol. 2016 Feb;10(2):240-52. doi: 10.1016/j.molonc.2015.09.010. Epub 2015 Oct 21.


[Fertility preservation and endometriosis: When medical borders on social].

Grynberg M, Benard J.

Gynecol Obstet Fertil. 2015 Dec;43(12):759-60. doi: 10.1016/j.gyobfe.2015.09.005. Epub 2015 Oct 23. French. No abstract available.


The past, present and future of fertility preservation in cancer patients.

Sonigo C, Sermondade N, Benard J, Benoit A, Shore J, Sifer C, Grynberg M.

Future Oncol. 2015 Oct;11(19):2667-2680. doi: 10.2217/fon.15.152. Epub 2015 Sep 11.


Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR binding.

Chu C, Noël-Hudson MS, Bénard J, Ha-Duong T, Allaoui F, Farinotti R, Bonhomme-Faivre L.

Eur J Pharm Sci. 2015 Aug 30;76:18-26. doi: 10.1016/j.ejps.2015.04.014. Epub 2015 Apr 27.


TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.

Selmi A, de Saint-Jean M, Jallas AC, Garin E, Hogarty MD, Bénard J, Puisieux A, Marabelle A, Valsesia-Wittmann S.

Cancer Lett. 2015 Feb 1;357(1):412-418. doi: 10.1016/j.canlet.2014.11.056. Epub 2014 Dec 1.


Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, Bénard J, Berbegall AP, Bown N, Combaret V, Couturier J, Erminio G, Gambini C, Garaventa A, Gross N, Haupt R, Kohler J, Jeison M, Lunec J, Marques B, Martinsson T, Noguera R, Parodi S, Schleiermacher G, Tweddle DA, Valent A, Van Roy N, Vicha A, Villamon E, Tonini GP.

Br J Cancer. 2015 Jan 20;112(2):290-5. doi: 10.1038/bjc.2014.557. Epub 2014 Nov 4.


Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma.

Gibert B, Delloye-Bourgeois C, Gattolliat CH, Meurette O, Le Guernevel S, Fombonne J, Ducarouge B, Lavial F, Bouhallier F, Creveaux M, Negulescu AM, Bénard J, Janoueix-Lerosey I, Harel-Bellan A, Delattre O, Mehlen P.

J Natl Cancer Inst. 2014 Oct 13;106(11). pii: dju318. doi: 10.1093/jnci/dju318. Print 2014 Nov.


Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers.

Oberthuer A, Juraeva D, Hero B, Volland R, Sterz C, Schmidt R, Faldum A, Kahlert Y, Engesser A, Asgharzadeh S, Seeger R, Ohira M, Nakagawara A, Scaruffi P, Tonini GP, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Vandesompele J, Speleman F, Noguera R, Piqueras M, Bénard J, Valent A, Avigad S, Yaniv I, Grundy RG, Ortmann M, Shao C, Schwab M, Eils R, Simon T, Theissen J, Berthold F, Westermann F, Brors B, Fischer M.

Clin Cancer Res. 2015 Apr 15;21(8):1904-15. doi: 10.1158/1078-0432.CCR-14-0817. Epub 2014 Sep 17.


Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients.

Gattolliat CH, Le Teuff G, Combaret V, Mussard E, Valteau-Couanet D, Busson P, Bénard J, Douc-Rasy S.

Cancer Med. 2014 Aug;3(4):998-1009. doi: 10.1002/cam4.264. Epub 2014 Jun 13.


[ROS1 fusion proteins, targets of foretinib].

Bénard J.

Bull Cancer. 2014 Jan 1;101(1):4. French. No abstract available.


WNT5A encodes two isoforms with distinct functions in cancers.

Bauer M, Bénard J, Gaasterland T, Willert K, Cappellen D.

PLoS One. 2013 Nov 18;8(11):e80526. doi: 10.1371/journal.pone.0080526. eCollection 2013.


[Explicative models of cancer biology: an enlarged vision].

Bénard J, Larsen CJ.

Bull Cancer. 2013 Jul-Aug;100(7-8):697-713. doi: 10.1684/bdc.2013.1752. Review. French.


In vitro maturation of oocytes: uncommon indications.

Grynberg M, El Hachem H, de Bantel A, Benard J, le Parco S, Fanchin R.

Fertil Steril. 2013 Apr;99(5):1182-8. doi: 10.1016/j.fertnstert.2013.01.090. Epub 2013 Feb 4. Review.


GALNT9 gene expression is a prognostic marker in neuroblastoma patients.

Berois N, Gattolliat CH, Barrios E, Capandeguy L, Douc-Rasy S, Valteau-Couanet D, Bénard J, Osinaga E.

Clin Chem. 2013 Jan;59(1):225-33. doi: 10.1373/clinchem.2012.192328. Epub 2012 Nov 7.


Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant.

Samy M, Gattolliat CH, Pendino F, Hillion J, Nguyen E, Bombard S, Douc-Rasy S, Bénard J, Ségal-Bendirdjian E.

Mol Cancer Ther. 2012 Nov;11(11):2384-93. doi: 10.1158/1535-7163.MCT-12-0281. Epub 2012 Aug 28.


Inhibition of P-glycoprotein functionality by vandetanib may reverse cancer cell resistance to doxorubicin.

Jovelet C, Bénard J, Forestier F, Farinotti R, Bidart JM, Gil S.

Eur J Pharm Sci. 2012 Aug 15;46(5):484-91. doi: 10.1016/j.ejps.2012.03.012. Epub 2012 Mar 30.


[Chromosomal rearrangements and fusion genes in carcinoma].

Massard C, Auger N, Lacroix L, Bénard J.

Bull Cancer. 2011 Dec;98(12):1395-401. doi: 10.1684/bdc.2011.1498. Review. French.


Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).

Schleiermacher G, Michon J, Ribeiro A, Pierron G, Mosseri V, Rubie H, Munzer C, Bénard J, Auger N, Combaret V, Janoueix-Lerosey I, Pearson A, Tweddle DA, Bown N, Gerrard M, Wheeler K, Noguera R, Villamon E, Cañete A, Castel V, Marques B, de Lacerda A, Tonini GP, Mazzocco K, Defferrari R, de Bernardi B, di Cataldo A, van Roy N, Brichard B, Ladenstein R, Ambros I, Ambros P, Beiske K, Delattre O, Couturier J.

Br J Cancer. 2011 Dec 6;105(12):1940-8. doi: 10.1038/bjc.2011.472. Epub 2011 Nov 10.


ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.

Bourdeaut F, Ferrand S, Brugières L, Hilbert M, Ribeiro A, Lacroix L, Bénard J, Combaret V, Michon J, Valteau-Couanet D, Isidor B, Rialland X, Poirée M, Defachelles AS, Peuchmaur M, Schleiermacher G, Pierron G, Gauthier-Villars M, Janoueix-Lerosey I, Delattre O; Comité Neuroblastome of the Société Francaise de Cancérologie.

Eur J Hum Genet. 2012 Mar;20(3):291-7. doi: 10.1038/ejhg.2011.195. Epub 2011 Nov 9.


Prenatal diagnosis of Milroy disease.

Benard J, Saada J, Amiel J, Vignes S, Benachi A, Picone O.

Prenat Diagn. 2011 Dec;31(12):1207-9. doi: 10.1002/pd.2864. Epub 2011 Oct 24. No abstract available.


Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma.

Gattolliat CH, Thomas L, Ciafrè SA, Meurice G, Le Teuff G, Job B, Richon C, Combaret V, Dessen P, Valteau-Couanet D, May E, Busson P, Douc-Rasy S, Bénard J.

Br J Cancer. 2011 Oct 25;105(9):1352-61. doi: 10.1038/bjc.2011.388. Epub 2011 Oct 4.


[RB, guardian of prostatic tumor progression].

Bénard J, Massard C.

Bull Cancer. 2011 Feb;98(2):91-2. French. No abstract available.


A multilocus technique for risk evaluation of patients with neuroblastoma.

Ambros IM, Brunner B, Aigner G, Bedwell C, Beiske K, Bénard J, Bown N, Combaret V, Couturier J, Defferrari R, Gross N, Jeison M, Lunec J, Marques B, Martinsson T, Mazzocco K, Noguera R, Schleiermacher G, Speleman F, Stallings R, Tonini GP, Tweddle DA, Valent A, Vicha A, Roy NV, Villamon E, Ziegler A, Preuner S, Drobics M, Ladenstein R, Amann G, Schuit RJ, Pötschger U, Ambros PF.

Clin Cancer Res. 2011 Feb 15;17(4):792-804. doi: 10.1158/1078-0432.CCR-10-0830.


[In vitro maturation of oocytes: an option for fertility preservation in women].

Grynberg M, Hesters L, Bénard J, Trèves R, Fanchin R, Frydman R, Frydman N.

J Gynecol Obstet Biol Reprod (Paris). 2011 Apr;40(2):103-8. doi: 10.1016/j.jgyn.2010.11.004. Epub 2011 Jan 13. Review. French.


Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.

Chauchereau A, Al Nakouzi N, Gaudin C, Le Moulec S, Compagno D, Auger N, Bénard J, Opolon P, Rozet F, Validire P, Fromont G, Fizazi K.

Exp Cell Res. 2011 Feb 1;317(3):262-75. doi: 10.1016/j.yexcr.2010.10.012. Epub 2010 Oct 23.


p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma.

Mergui X, Puiffe ML, Valteau-Couanet D, Lipinski M, Bénard J, Amor-Guéret M.

BMC Cancer. 2010 Sep 2;10:473. doi: 10.1186/1471-2407-10-473.


Prognostic impact of gene expression-based classification for neuroblastoma.

Oberthuer A, Hero B, Berthold F, Juraeva D, Faldum A, Kahlert Y, Asgharzadeh S, Seeger R, Scaruffi P, Tonini GP, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Vandesompele J, Vermeulen J, Speleman F, Noguera R, Piqueras M, Bénard J, Valent A, Avigad S, Yaniv I, Weber A, Christiansen H, Grundy RG, Schardt K, Schwab M, Eils R, Warnat P, Kaderali L, Simon T, Decarolis B, Theissen J, Westermann F, Brors B, Fischer M.

J Clin Oncol. 2010 Jul 20;28(21):3506-15. doi: 10.1200/JCO.2009.27.3367. Epub 2010 Jun 21.


CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells.

Bettayeb K, Baunbæk D, Delehouze C, Loaëc N, Hole AJ, Baumli S, Endicott JA, Douc-Rasy S, Bénard J, Oumata N, Galons H, Meijer L.

Genes Cancer. 2010 Apr;1(4):369-80. doi: 10.1177/1947601910369817.


Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.

Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P, Benard J, Forget S, Blanchard C, Dômont J, Bonvalot S, Guillou L, Leroux A, Mechine-Neuville A, Schöffski P, Laë M, Collin F, Verola O, Carbonnelle A, Vescovo L, Bui B, Brouste V, Sobol H, Aurias A, Coindre JM.

Genes Chromosomes Cancer. 2010 Jun;49(6):560-8. doi: 10.1002/gcc.20766.


High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management.

Dômont J, Salas S, Lacroix L, Brouste V, Saulnier P, Terrier P, Ranchère D, Neuville A, Leroux A, Guillou L, Sciot R, Collin F, Dufresne A, Blay JY, Le Cesne A, Coindre JM, Bonvalot S, Bénard J.

Br J Cancer. 2010 Mar 16;102(6):1032-6. doi: 10.1038/sj.bjc.6605557. Epub 2010 Mar 2.


Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis.

Bouzas-Rodriguez J, Cabrera JR, Delloye-Bourgeois C, Ichim G, Delcros JG, Raquin MA, Rousseau R, Combaret V, Bénard J, Tauszig-Delamasure S, Mehlen P.

J Clin Invest. 2010 Mar;120(3):850-8. doi: 10.1172/JCI41013. Epub 2010 Feb 15.


Configural processing enables discrimination and categorization of face-like stimuli in honeybees.

Avarguès-Weber A, Portelli G, Benard J, Dyer A, Giurfa M.

J Exp Biol. 2010 Feb 15;213(4):593-601. doi: 10.1242/jeb.039263.


A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2.

Hangen E, De Zio D, Bordi M, Zhu C, Dessen P, Caffin F, Lachkar S, Perfettini JL, Lazar V, Benard J, Fimia GM, Piacentini M, Harper F, Pierron G, Vicencio JM, Bénit P, de Andrade A, Höglinger G, Culmsee C, Rustin P, Blomgren K, Cecconi F, Kroemer G, Modjtahedi N.

Cell Death Differ. 2010 Jul;17(7):1155-66. doi: 10.1038/cdd.2009.211. Epub 2010 Jan 29.


Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.

Vermeulen J, De Preter K, Naranjo A, Vercruysse L, Van Roy N, Hellemans J, Swerts K, Bravo S, Scaruffi P, Tonini GP, De Bernardi B, Noguera R, Piqueras M, Cañete A, Castel V, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Michon J, Combaret V, Fischer M, Oberthuer A, Ambros PF, Beiske K, Bénard J, Marques B, Rubie H, Kohler J, Pötschger U, Ladenstein R, Hogarty MD, McGrady P, London WB, Laureys G, Speleman F, Vandesompele J.

Lancet Oncol. 2009 Jul;10(7):663-71. doi: 10.1016/S1470-2045(09)70154-8. Epub 2009 Jun 8.


MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S.

Bénard J, Raguénez G, Kauffmann A, Valent A, Ripoche H, Joulin V, Job B, Danglot G, Cantais S, Robert T, Terrier-Lacombe MJ, Chassevent A, Koscielny S, Fischer M, Berthold F, Lipinski M, Tursz T, Dessen P, Lazar V, Valteau-Couanet D.

Mol Oncol. 2008 Oct;2(3):261-71. doi: 10.1016/j.molonc.2008.07.002. Epub 2008 Jul 23.

Supplemental Content

Loading ...
Support Center